Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma - Concepedia

Concepedia

Publication | Open Access

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

DOI Full Paper Access

334

Citations

46

References

2009

Year

Melanie B. Thomas, Jeffrey S. Morris, Romil Chadha, Michiko Iwasaki, Harmeet Kaur, Elinor Lin, Ahmed O. Kaseb, Katrina Y. Glover, Marta Davila, James L. Abbruzzese

Journal of Clinical Oncology

Abstract

The combination of B + E in patients who had advanced HCC showed significant, clinically meaningful antitumor activity. B + E warrant additional evaluation in randomized controlled trials.

References

	Year	Citations

Page 1